SPR no: 56C1476824
MRN no: 020062
Site_name: SGP
Facility_id: MR
Specimen_type: Fresh Tissue
Pathology ReportSUPPLEMENTARY REPORT 17/2/71

56C14768 (56C1476824) Morand, Elliott
HISTOPATHOLOGY REPORT
WEIPA HOSPITAL AND SUTHERLAND HOSPITAL LABORATORIES

CLINICAL NOTES:
L mastectomy / axilla.  DCIS medial Ca [illegible].

MACROSCOPIC:
&amp;quot;LEFT BREAST + CLEARANCE&amp;quot;.
SPECIMEN SIDE:  Left
SPECIMEN TYPE:  Mastectomy
SPECIMEN X-RAY:  No
HOOKWIRE:  No
SPECIMEN DIMENSIONS:  300x180x70mm
WEIGHT:  1435g
SKIN:  230x95mm
NIPPLE:  13mm
MUSCLE:  No
MARGINS INKED Non-standard:  Anterosuperior blue, anteroinferior green, posterior black
Specimen bi-valved in the coronal plane with a medial hinge followed by multiple parasagittal slices of anterior and posterior halves.
OTHER TISSUE:  Axillary tail attached 80x70x30mm.
FINDINGS / LESION:  At 1 o&amp;apos;clock there is a firm, ill-defined, lobulated lesion 15x10mm.  It is clear (more than 30mm) from all margins.  At 12 to 1 o&amp;apos;clock, there is a haemorrhagic cavity measuring 50x20x20mm, surrounded by fibrohaemorrhagic areas.  No definite firm lesion identified.
(1 nipple; 2&amp;amp;3 composite section of 1 o&amp;apos;clock tumour; 4&amp;amp;5 second portion of tumour deeper; 6-13 cavity anterior portion; 14-19 cavity posterior portion; 20 posterior margin of cavity; 21&amp;amp;22 section of 1 o&amp;apos;clock tumour composite section with posterior margin; 23&amp;amp;24 composite section anterior to the 1 o&amp;apos;clock tumour; 25 upper outer quadrant; 26 lower outer quadrant; 27 inner lower quadrant;
Axillary tail separated and multiple lymph nodes identified macroscopically, maximum dimension of 40mm with a firm white surface.
28 one section of involved lymph node; 29 one section of involved lymph node; 30&amp;amp;31 one lymph node sectioned;  32&amp;amp;33 one lymph node sectioned; 34&amp;amp;35 one lymph node sectioned; 36-43 ?two lymph nodes each.  RS (M-43).
B.  &amp;quot;MORE AXILLARY TISSUE&amp;quot;.  Fibrous tissue 15x10x5mm, possible lymph node 5mm.  AE (1-1/SM 2/6/2068 nh)
MICROSCOPIC: (Dr O Brokins)
&amp;#160;



INVASIVE BREAST CANCER SYNOPTIC REPORT (Based on CAP 2017)
SPECIMENS AND B
&amp;#160;
INVASIVE CARCINOMA:
&amp;#160;
NUMBER OF INVASIVE FOCI: Multiple invasive foci
Number and size of individual foci: Two foci 14 and 3mm
&amp;#160;
MAXIMUM INVASIVE TUMOUR SIZE: &amp;#160;14mm
&amp;#160;
INVASIVE CARCINOMA TYPE: Invasive carcinoma of no special type (ductal)
&amp;#160;
HISTOLOGIC GRADE: 3
&amp;#160;
SCORES: Tubules: 3, Nucle: 3, Mitoses: 3; Total score: 9
&amp;#160;
MITOTIC RATE: 44&amp;#160;&amp;#160;mitoses per 10 high power fields
&amp;#160;
WHOLE TUMOUR SIZE (INVASIVE + DCIS):
Tumour 1: 14mm
Tumour 2: 30mm  (3mm invasive within 30mm DCIS)
&amp;#160;
PERITUMOURAL LYMPHOVASCULAR INVASION: Present and extensive
&amp;#160;
PERINEURAL INVASION:Not identified

SKIN INVOLVEMENT: Not identified
DERMAL LYMPHOVASCULAR INVASION: Not identified
NIPPLE INVOLVEMENT: Not identified
MUSCLE INVOLVEMENT: Not applicable
&amp;#160;
DUCTAL CARCINOMA IN SITU (DCIS): &amp;#160;Present
DCIS size / extent: DCIS present within 14mm tumour and spanning 30mm in association with 3mm tumour
Nuclear grade: High
Architecture / type: Solid, cribrifom
Necrosis: Present
Microcalcification of DCIS: Present
Extensive intraduct component: Negative

LOBULAR CARCINOMA IN SITU (LCIS): &amp;#160;Not identified

EXCISION MARGINS
INVASIVE TUMOUR MARGINS: Clear, by more than 10mm
DCIS MARGINS: Clear, by more than 10mm
&amp;#160;
ANCILLARY TESTS:
IMMUNOSTAINS, block A2&amp;#160;
ER: Positive &amp;#160;98%, &amp;#160;2+
PgR: Positive &amp;#160;95%, &amp;#160;3+&amp;#160;
HER2: Negative 1+ (IHC, SISH to follow)
Ki67: 40 to 50%
&amp;#160;
Other tumour block suitable for further testing: A4
&amp;#160;&amp;#160;
LYMPH NODES
AXILLARY LYMPH NODES: Involved
Number of involved lymph nodes: 9
Total number of nodes examined: 22
&amp;#160;
Largest nodal tumour deposit: 21 mm
Extranodal extension: Not identified

PATHOLOGIC STAGE CLASSIFICATION (AJCC, TNM 8th edition): pT1c  , pN2a


DIAGNOSIS:

A, B. LEFT BREAST AND AXILLA -
-  TWO FOCI OF GRADE 3 INVASIVE DUCTAL CARCINOMA, 14 AND 3mm MAXIMUM EXTENT, MARGINS CLEAR. ASSOCIATED HIGH GRADE DCIS
-  EXTENSIVE LYMPHOVASCULAR SPACE INVASION
-  NINE OF TWENTY TWO AXILLARY LYMPH NODES INVOLVED BY METASTATIC CARCINOMA.
2/8/71 ld
SUPPLEMENTARY REPORT 17/3/71
HER-2 IN-SITU HYBRIDISATION
Signal Detection has been performed for the HER2 gene (17q21) and chromosome 17 centromeric enumeration probe (CEP17) control using the Ventana INFORM HER2 Dual ISH DNA Probe Cocktail Assay (Roche).
HER2 Dual ISH result:   NEGATIVE
Mean HER2 copy number per cell:  3.4
Mean CEP17 copy number per cell:  1.75
HER2/CEP17 Ratio:  1.9
SCORING CRITERIA (Update in line with ASCO/CAP recommendations 2013):
Negative: HER2/CEP17 &amp;lt; 2.0, Average HER2 &amp;lt; 4.0
Equivocal:&amp;#160; HER2/CEP17 &amp;lt; 2.0, Average HER2 &amp;gt; or equal to 4.0 and &amp;lt; 6.0
Positive: HER2/CEP17 &amp;lt; 2.0, Average HER2 &amp;gt; or equal to 6.0
Positive: HER2/CEP17 &amp;gt; or equal to 2.0
Reported by: Dr O Scholer
Date: 15/2/71
